CLINICAL ROLE -
A Bevacizumab Biosimilar Shows Promise for Non-Small Cell Lung Cancer
BAT1706 was clinically equivalent to the reference bevacizumab for efficacy, safety, pharmacokinetics, and immunogenicity.
Assessment-Guided Interventions for Elderly Multiple Myeloma Patients Highlight Benefit of Oncology Pharmacists
Patients readily accepted physical interventions and referrals to oncology clinical pharmacy practitioners.
Adalimumab Biosimilar Shows Efficacy in Noninfectious Uveitis
Switching from adalimumab originator to SB5 did not cause clinically significant differences in treatment efficacy and safety for patients with noninfectious uveitis.
Study Evaluates Oncology Pharmacist Prescribing Tendencies in Ambulatory Care in Canada
In the ambulatory setting, oncology pharmacists independently prescribe medications to support and manage therapy toxicities for cancer patients.
Investigating Etoposide Adverse Reactions Associated with Polyethersulfone Filter
This study showed the importance of a multidisciplinary team’s expertise to investigate a clinical inquiry beyond the scope of the clinicians’ skillset and their access to necessary technology.
2 Commerce Drive Cranbury, NJ 08512